Flt3L and CD40 agonism enhance dendritic cell immunosurveillance in human and murine pancreatic cancer and engage type I immunity.
Combined Flt3L and CD40 agonism restores dendritic cell–driven T cell immunity in pancreatic cancer | Science Immunology
